Antiepileptic drug development for "therapeutic orphans"

Epilepsia

Volumn 44, Issue SUPPL. 7, 2003, Pages 19-25

  Trevathan, Edwin ^a  

^a ST LOUIS CHILDREN S HOSPITAL   (United States)

Author keywords

Antiepileptic drugs; Clinical trials; Pediatric epilepsy

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CORTICOTROPIN; DIAZEPAM; ETHOSUXIMIDE; ETIRACETAM; FELBAMATE; GABAPENTIN; LAMOTRIGINE; LORAZEPAM; MIDAZOLAM; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PREDNISONE; TIAGABINE; TOPIRAMATE; VALPROIC ACID; ZONISAMIDE;

CHILD; CLINICAL TRIAL; CONFERENCE PAPER; DISEASE CLASSIFICATION; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG DISTRIBUTION; DRUG HALF LIFE; DRUG INDUSTRY; DRUG RESEARCH; DRUG SCREENING; EPILEPSY; ETHICS; FINANCIAL MANAGEMENT; GOVERNMENT; HUMAN; INCIDENCE; INFORMED CONSENT; MARKET; ONSET AGE; PRIORITY JOURNAL; REGULATORY MECHANISM; SEIZURE; TABLET FORMULATION;

EID: 0042917428     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1528-1157.44.s7.1.x     Document Type: Conference Paper

References (55)

1. Hauser WA. Incidence and prevalence. In: Engel J, Pedley TA, eds. Epilepsy: a comprehensive texbook. Philadelphia: Lippincott-Raven Publishers, 1998:47-57.
2. Murphy CC, Trevathan E, Yeargin-Allsopp M. The prevalence of epilepsy in ten-year-old children: Results from the Metropolitan Atlanta Developmental Disabilities Study. Epilepsia 1995;36:866-72.
3. Dodson WE. Pharmacokinetic principles of antiepileptic therapy in children. In: Pellock JM, Dodson WE, Bourgeois BFD, eds. Pediatric epilepsy: diagnosis and therapy. New York: Demos Medical Publishing, 2001:317-27.
4. McBride MC, Laroia N, Guillet R. Electrographic seizures in neonates correlate with poor neurodevelopmental outcome. Neurology 2000;55:506-13.
5. Painter MJ, Scher MS, Stein AD, et al. Phenobarbital compared with phenytoin for the treatment of neonatal seizures. N Engl J Med 1999;341:485-9.
6. Trevathan E. Epilepsy syndrome-specific anti-epileptic drug therapy for children. Lancet 2000;356:1623-4.
7. Editorial. How to best serve children. Lancet 2000;356:1619.
8. Chiron C, Dumas C, Jambaque I, Mumford J, Dulac O. Randomized trial comparing vigabatrin and hydrocortisone in infantile spasms due to tuberous sclerosis. Epilepsy Res 1997;26:389-95.
9. Chiron C, Marchand MC, Tran A, et al. Stiripentol in severe myoclonic epilepsy in infancy: a randomized placebo-controlled syndrome-dedicated trial. Lancet 2000;356:1638-42.
10. Children's Oncology Group. http://www.childrensoncologygroup.org (Accessed 5/12/03).
11. Frank LM, Enlow T, Holmes GL, et al. Lamictal (lamotrigine) monotherapy for typical absence seizures in children. Epilepsia 1999;40:973-9.
12. Wirrell EC, Camfield CS, Camfield PR, Gordon KE, Dooley JM. Long-term prognosis of typical childhood absence epilepsy: remission or progression to juvenile myoclonic epilepsy. Neurology 1996;47:912-8.
13. Wong M, Trevathan E. Infantile spasms. Pediatric Neurol 2001;24:89-98.
14. Harding BN. Progressive neuronal degeneration of childhood with liver disease (Alpers-Huttenlocher syndrome): a personal review. J Child Neurol 1990;5:273-87.
15. Bryant AE, Dreifuss FE. Valproic acid hepatic fatalities. III. U.S. experience since 1986. Neurology 1996;46:465-9.
16. Pellock JM. Pediatric trials: practical issues. In: French J, Leppik, Dichter MA, eds. Antiepileptic drug development, Philadelphia: Lippincott-Raven Publishers, 1998:167-71.
17. Steinbrook R. Testing medications in children. N Engl J Med 2002;347:1462-70.
18. American Academy of Pediatrics. FDA Pediatric rule court decision and the next step for congress. http://www.aap.org/advocacy/washing/fdadrugrule_1018.htm (Accessed 11/1/02).
19. Sixth Eilat Conference on new antiepileptic drugs (Eilat VI), Taormina, Sicily, Italy, April 7-11, 2002.
20. Duchowny M, Pellock JM, Graf WD, et al. A placebo-controlled trial of lamotrigine add-on therapy for partial seizures in children. Neurology 1999;53:1724-31.
21. Elterman RD, Glauser RA, Wyllie E, Reife R, Wu SC, Pledger G. and the Topiramate YP Study Group. A double-blind, randomized trial of topiramate as adjunctive therapy for partial-onset seizures in children. Neurology 1999;52:1338-44.
22. Appleton R, Fichtner K, LaMOreaux L, et al. Gabapentin as add-on therapy in children with refractory partial seizures: a 12-week, multicentre, double-blind, placebo-controlled study. Epilepsia 1999;40:1147-54.
23. Hes MS, Trudeau VL, Kilgore MB, et al. A double-blind, placebo-controlled randomized multicenter trial of gabapentin in pediatric patients with BECTS [Abstract]. Epilepsia 1995;36(suppl 4):S125.
24. Uldall P, Buiteau C, Pederson SA, Dulac O, Lyby K. Single-blind study of safety, tolerability, and preliminary efficacy of tiagabine as adjunctive treatment of children with epilepsy [Abstract]. Epilepsia 1995;36(suppl 3):S147.
25. de Silva M, MacArdle B, McGowan M, et al. Randomized comparative monotherapy trial of phenobarbitone, phenytoin, carbamazepine or sodium valproate for newly diagnosed childhood epilepsy. Lancet 1996;347:709-13.
26. Glauser TA, Nigro M, Sachdeo R, et al. Adjunctive therapy with oxcarbazepine in children with partial seizures. Neurology 2000;54:2237-44.
27. Pal DK, Das T, Chaudhury G, Johnson AL, Neville BG. Randomized controlled trial to assess acceptability of phenobarbital for childhood epilepsy in rural India. Lancet 1998;351:19-23.
28. Vining EP, Mellitis ED, Dorsen MM, et al. Psychologic and behavioral effects of antiepileptic drugs in children: a double-blind comparison between phenobarbital and valproic acid. Pediatrics 1987;80:165-74.
29. Glauser TA, Pellock JM. Zonisamide in pediatric epilepsy: review of the Japanese experience. J Child Neural 2002;17:87-96.
30. Biton V, Montouris GD, Ritter F, et al. A randomized, placebo-controlled study of topiramate in primary generalized tonic-clonic seizures. Topiramate YTC Study Group. Neurology 1999;52:1330-7. [Published Erratum in Neurology 1999;53:1162.]
31. Sachdeo RC, Glauser TA, Ritter F, Reife R, Lim P, Pledger G, and the Topiramate YL Study Group. A double-blind, randomized trial of topiramate in Lennox-Gastaut syndrome. Neurology 1999;52:1882-7.
32. Motte J, Trevathan E, Arvidsson JFV, Barrera MN, Mullens EL, Manasco P, and the Lamictal Lennox-Gastaut Study Group. Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome. N Engl J Med 1997;337:1807-12. [Published Erratum in N Engl J Med 1998;339:851-2.]
33. Eriksson AS, Nergardh A, Hoppu K. The efficacy of lamotrigine in children and adolescents with refractory generalized epilepsy: a randomized, double-blind, crossover study. Epilepsia 1998;39:495-501.
34. The Felbamate Study Group in Lennox-Gastaut Syndrome. Efficacy of felbamate in childhood epileptic encephalopathy (Lennox-Gastaut Syndrome). N Engl J Med 1993;328:29-33.
35. Siegel H, Kelley K, Stertz B, et al. The efficacy of felbamate as add-on therapy to valproic acid in the Lennox-Gastaut syndrome. Epilepsy Res 1999;34:91-7.
36. The Group for the Evaluation of Cinromide in the Lennox-Gastaut Syndrome. Double-blind, placebo-controlled evaluation of cinromide in patients with Lennox-Gastaut Syndrome. Epilepsia 1989;30:422-9.
37. Hrachovy RA, Frost JD, Kellaway PR, Zion TE. A controlled study of ACTH vs prednisone therapy in infantile spasms. J Pediatr 1983;103:641-5.
38. Baram TZ, Mitchell WG, Tournay A, Snead OC, Hanson RA, Horton EJ. High-dose corticotropin (ACTH) versus prednisone for infantile spasms: a prospective, randomized, blinded study. Pediatrics 1996;97:375-9.
39. Dreifuss F, Farwell J, Holmes GL, et al. Infantile spasms: comparative trial of nitrazepam and corticotropin. Arch Neurol 1986;43:1107-10.
40. Vigevano F, Cilio MR. Vigabatrin versus ACTH as first-line treatment for infantile spasms: a randomized, prospective study. Epilepsia 1997;38:1270-4.
41. Dyken PR, DuRant RH, Minden DB, King DW. Short term effects of valproate on infantile spasms. Pediatr Neural 1985;1:34-7.
42. Elterman RD, Shields WD, Mansfield KA, Nakagawa J, and the US Infantile Spasms Vigabatrin Study Group. Randomized trial of vigabatrin in patients with infantile spasms. Neurology 2001;57:1416-21.
43. Vigevano F, Cilio MR. Vigabatrin versus ACTH as first-line treatment for infantile spasms: a randomized, prospective study. Epilepsia 1997;38:1270-4.
44. Luna D, Dulac O, Pajot N, Beaumont D. Vigabatrin in the treatment of childhood epilepsies: a single-blind placebo-controlled study. Epilepsia 1989;30:430-7.
45. Bernardina BD, Fontana E, Vigevano F, et al. Efficacy and tolerability of vigabatrin in children with refractory partial seizures: a single-blind dose-increasing study. Epilepsia 1995;36:687-91.
46. Trudeau V, Myers S, LaMoreaux L, Anhut H, Garofalo E, Ebersole J. Gabapentin in naïve childhood absence epilepsy: results from two double-blind, placebo-controlled, multicenter studies. J Child Neurol 1996;11:470-5.
47. Callaghan N, O'Hare J, O'Driscoll D, O'Neill B, Daly M. Comparative study of ethosuximide and sodium valproate in the treatment of typical absence seizures (petit mal). Dev Med Child Neurol 1982;24:830-6.
48. Sato S, White BG, Penry JK. Valproic acid versus ethosuximide in the treatment of absence seizures. Neurology 1982;32:157-63.
49. Suzuki M, Maruyama H, Ishibashi Y, et al. A double-blind comparative trial of sodium dipropylacetate and ethosuximide in epilepsy in children with special emphasis on pure petit mal seizures. Med Prog 1972;82:470-88.
50. Bruni J, Wilder BJ, Bauman AW, Willmore LJ. Clinical efficacy and long-term effects of valproic acid therapy on spike-and-wave discharges. Neurology 1980;30:42-6.
51. Erenberg G, Rothner AD, Henry CE, Cruse RP. Valproic acid in the treatment of intractable absence seizures in children. A single-blind clinical and quantitative EEG study. Am J Dis Child 1982;136:526-9.
52. Dreifuss FE, Rosman NP, Cloyd JC, et al. A comparison of rectal diazepam gel and placebo for acute repetitive seizures. N Engl J Med 1998;338:1869-75.
53. Cereghino JJ, Mitchell W, Murphy J, Kriel RL, Rosenfeld WE, Trevathan E. Treating repetitive seizures with a rectal diazepam formulation: a randomized study. Neurology 1998;51:1274-82.
54. Rosman NP, Colton T, Labazzo J, et al. A controlled trial of diazepam administered during febrile illnesses to prevent recurrence of febrile seizures. N Engl J Med 1993;329:79-84.
55. Chamberlain JM, Altieri MA, Futterman C, Young GM, Ochsenschlager DW, Waisman Y. A prospective, randomized study comparing intramuscular midazolam with intravenous diazepam for the treatment of seizures in children. Pediatr Emerg Care 1997;13:92-4.